Login / Signup

Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with 'aggressive' multiple sclerosis.

Joyutpal DasJ A SnowdenJoachim BurmanM S FreedmanH AtkinsM BowmanR K BurtR SaccardiC InnocentiS MistryP J LaudH JessopB Sharrack
Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2021)
AHSCT is safe and effective as a first-line DMT in inducing rapid and sustained remission in patients with 'aggressive' MS.
Keyphrases
  • stem cell transplantation
  • multiple sclerosis
  • high dose
  • cell therapy
  • white matter
  • mass spectrometry
  • bone marrow
  • disease activity
  • platelet rich plasma
  • stem cells
  • loop mediated isothermal amplification